Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines 01 April
Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 08 March
Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy 08 March
